Auction result of Treasury Bonds - RIKB 29 0416
Tweet
Share
E-mail| Series | RIKB 29 0416 | ||
| Settlement Date | 05/13/2026 | ||
| Total Amount Allocated (MM) | 24,956 | ||
| All Bids Awarded At (Price / Yield) | 100.209 | / | 7.660 |
| Total Number of Bids Received | 55 | ||
| Total Amount of All Bids Received (MM) | 37,226 | ||
| Total Number of Successful Bids | 40 | ||
| Number of Bids Allocated in Full | 40 | ||
| Lowest Price / Highest Yield Allocated | 100.209 | / | 7.660 |
| Highest Price / Lowest Yield Allocated | 100.489 | / | 7.550 |
| Lowest Price / Highest Yield Allocated in Full | 100.209 | / | 7.660 |
| Weighted Average of Successful Bids (Price/Yield) | 100.303 | / | 7.620 |
| Best Bid (Price / Yield) | 100.489 | / | 7.550 |
| Worst Bid (Price / Yield) | 99.954 | / | 7.760 |
| Weighted Average of All Bids Received (Price / Yield) | 100.226 | / | 7.650 |
| Percentage Partial Allocation (Approximate) | 100.00 % | ||
| Bid to Cover Ratio | 1.49 | ||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA
- The Jackson Laboratory, with the Broad Institute and Partners, Selected for ARPA-H THRIVE Award to Advance Gene Editing Platform for Pediatric Epilepsies and Rare CNS Diseases
- Mzeldravoq Review: Is Mzeldravoq the Smartest Trading Platform of 2026?
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
